000 | 00911 a2200265 4500 | ||
---|---|---|---|
005 | 20250517222257.0 | ||
264 | 0 | _c20181107 | |
008 | 201811s 0 0 eng d | ||
022 | _a2046-8962 | ||
024 | 7 |
_a10.4155/ppa-2018-0010 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLim, Daniel | |
245 | 0 | 0 |
_aDisruption and development: the evolving CRISPR patent and technology landscape. _h[electronic resource] |
260 |
_bPharmaceutical patent analyst _c07 2018 |
||
300 |
_a141-145 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAcademies and Institutes |
650 | 0 | 4 | _aCRISPR-Cas Systems |
650 | 0 | 4 | _aCalifornia |
650 | 0 | 4 | _aPatents as Topic |
650 | 0 | 4 | _aTechnology |
650 | 0 | 4 | _aUniversities |
773 | 0 |
_tPharmaceutical patent analyst _gvol. 7 _gno. 4 _gp. 141-145 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4155/ppa-2018-0010 _zAvailable from publisher's website |
999 |
_c28510861 _d28510861 |